
Excitement is building as a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer’s disease.
Led by an expert from the University of Nevada in the US and published in the journal Alzheimer’s & Dementia: Translational Research and Clinical Interventions, the review reveals that 182 clinical trials are underway in 2025, a rise of 11% from the previous year, assessing the impact 138 potential drugs.